<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
49281-726-10
</NDCCode>
<PackageDescription>
10 SYRINGE in 1 CARTON (49281-726-10) / .5 mL in 1 SYRINGE (49281-726-88)
</PackageDescription>
<NDC11Code>
49281-0726-10
</NDC11Code>
<ProductNDC>
49281-726
</ProductNDC>
<ProductTypeName>
VACCINE
</ProductTypeName>
<ProprietaryName>
Flublok Trivalent Northern Hemisphere
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Influenza A Virus A/missouri/11/2025 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/darwin/1415/2025 (h3n2) Recombinant Hemagglutinin Antigen, And Influenza B Virus B/pennsylvania/14/2025 Recombinant Hemagglutinin Antigen
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR
</RouteName>
<StartMarketingDate>
20260702
</StartMarketingDate>
<EndMarketingDate>
20270630
</EndMarketingDate>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA125285
</ApplicationNumber>
<LabelerName>
Sanofi Vaccines US Inc.
</LabelerName>
<SubstanceName>
INFLUENZA A VIRUS A/MISSOURI/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/DARWIN/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PENNSYLVANIA/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN
</SubstanceName>
<StrengthNumber>
45; 45; 45
</StrengthNumber>
<StrengthUnit>
ug/.5mL; ug/.5mL; ug/.5mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-07-06
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20260702
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20270630
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>